Senator Feinstein Pens Letter to Stronach Group About Golden Gate Closure

California Senator Dianne Feinstein issued a letter Wednesday to The Stronach Group (TSG), which owns Golden Gate Fields, requesting answers to the reasons behind the planned closure of the track at the end of the year, and the impacts from the company's decision on other industry sectors.

Since TSG announced on July 15 with a short statement light on detail the closure of Golden Gate Fields–a momentous decision that figures to upend a way of life for many in California–the company has remained publicly mum when pressed about the decision.

“I appreciate the steps The Stronach Group has taken in recent years to address equine safety and welfare concerns at your tracks and for your ongoing operation of Santa Anita Park. Nevertheless, your decision to close Golden Gate Fields will affect many California residents and merits further explanation,” wrote Feinstein, in a letter posted on the senator's website. The Los Angeles Times first reported the missive.

In the letter, Feinstein details the following questions that she enjoins the company to answer:

  • What is your rationale for closing Golden Gate Fields and why did you choose December 2023 as the closure date?
  • Will you help employees of Golden Gate Fields find other work in the horseracing industry or elsewhere? If so, which employees and how? Will you offer them positions at the other racetracks you operate?
  • What are the plans for the land?
  • How will the closure impact the other track you operate at Santa Anita Park?

“Golden Gate Fields has hosted horse racing since 1941 and is the last remaining full-time horse racing track in Northern California. As you have noted, your decision will have profound impacts on the livelihoods of the permanent and race-day employees at Golden Gate Fields as well as regional horse owners, trainers, jockeys, and stable personnel that consider it their home track,” Feinstein wrote.

Feinstein's letter follows TDN's own efforts to elicit answers from TSG about the closure of Golden Gate.

Between July 16 and July 24, TDN submitted each day to TSG a series of questions covering a variety of issues. TSG responded only once. “For now, the [Sunday] statement is going to be our comment around the story. We look forward to being in touch in the future about our plans,” wrote Stefan Friedman, a TSG spokesperson.

In light of the ongoing information blackout, the TDN published those questions on Monday in an open letter to the company, asking when stakeholders can expect the details they need to make tough long-term business decisions.

Feinstein has inserted herself before in this manner into California racing industry matters.

In late 2021 after the sudden death of GI Kentucky Derby winner Medina Spirit (Protonico), Feinstein called on the California Horse Racing Board (CHRB) to conduct a “thorough, transparent and independent investigation.”

The post Senator Feinstein Pens Letter to Stronach Group About Golden Gate Closure appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Greg Ferraro Q&A, Part II: HISA Rollout “Inconsistent and Uneven”

After Sunday's announcement that The Stronach Group (TSG) will close at the end of the year its flagship Northern California racetrack, Golden Gate Fields, the company at the helm of the sale has gone silent, ignoring all of TDN's requests for comment this week.

To bring much-needed illumination on this seismic decision, the TDN spoke Thursday morning with Greg Ferraro, the California Horse Racing Board (CHRB) chairman.

Among several points raised, Ferraro shared his thoughts on the need for a fixed hub of racing in Northern California to secure the long-term viability of the state's racing industry, and for necessary renovations of Santa Anita's backstretch accommodation as a condition of licensure at the track.

Ferraro also expressed concern that TSG has not fully considered the potentially stark ramifications from Golden Gate's closure on the rest of the state's stakeholders, including the breeders, owners, trainers and other licensees.

“I have the feeling–I don't know–but I have the feeling since The Stronach Group hasn't put anything out there yet, that perhaps they don't have their plans fully developed,” Ferraro said.

Read part one of the interview here.

The CHRB chair, however, didn't just speak on Golden Gate Fields. Ferraro also shared his thoughts and concerns surrounding the ongoing rollout of the Horseracing Integrity and Safety Act (HISA)'s Anti-Doping and Medication Control (ADMC) program.

Part two of this interview has been lightly edited for brevity and clarity.

TDN: Let's shift gears and move on to the ongoing rollout of HISA's Anti-Doping and Medication Control program. Very broadly, how would you assess the job they've done so far?

GF: I would say it's inconsistent and uneven.

Their rules are somewhat complicated for people. Sometimes they haven't made things completely clear. But their application of the rules and their disciplinary actions have been uneven and inconsistent.

What the basic plan is, is to make a major cultural change in the way racing operates. And in order to do that, you have to have some trust within the industry. I don't think their initial steps have built any sense of trust. So going forward, the industry's a little reticent, let's put it that way.

TDN: What specifics can you point to when you say, 'inconsistent and uneven'?

GF: The incident with the joint injections where some trainers were fine and others weren't. Some horses were disqualified and others weren't. They withheld the names of violating trainers for a long time. Nineteen trainers.

Then there's the inconsistency in the enforcement of this provisional suspension [in the event of a positive for a banned substance]. That's been quite a concern to trainers because a trainer could be put out of business with basically no warning, the way they are going about it.

From a California point of view, we're always quite concerned about due process. [Trainer Ray] Handal is a perfect example. They suspended him. Then, once they looked into it, they found out it was contamination in the feed. It's happened before. The mill runs the cattle feed before they run the horse feed, and the horse feed is contaminated.

So here, this guy is knocked out of business for [nearly] a week, traumatized financially and emotionally, and then it's reversed.

[Note: Read more on the Handal situation here.]

Instead, if they had they just notified the trainer, investigated for a few days and had a hearing before [potentially] suspending somebody, it seems to me that's a fairer way to go. I think most of the trainers in California are used to that kind of system, and that's their feeling as well.

TDN: What you're saying is the current system of an automatic provisional suspension after a positive for a banned substance needs to be eliminated or modified?

GF: Yes. Given the American jurisprudence system of innocence until proven guilty and due process, I think it needs to be reorganized.

TDN: You mentioned joint injections. In California prior to HISA, the intra-articular corticosteroid fetlock injection rule mandated a 30-day stand down period prior to racing, and all intra-articular corticosteroid joint injections had a 10-day stand down before workouts. HISA's intra-articular joint injection rule requires a 14-day stand down before racing and a seven-day stand down before workouts. Do these weaker intra-articular joint injection rules concern you?

GF: Yes, that's a concern to us. It's a step backwards for California. We noticed once we put that rule in place in California, we dropped the musculoskeletal breakdowns dramatically. So, we think it's important.

We tried to get HISA to go along with [California's rules], but they wouldn't. We're still in discussions with them about it. We've cooperated a lot with HISA and we've been supportive of them. And I don't want to come across as being negative of HISA. But for California, you know, it's a bit of a step backward. It's a big expense. And we're not getting that much out of it because we've been ahead of the game nationally for quite some time now.

The corticosteroid issue is something they need to take another look at. Corticosteroids are not bad per se. But corticosteroids and high-speed works combined are not good at all.

Take any athlete that goes into training. Over time, their joint health degenerates. It's just part of what happens. You wear the surfaces down. You can't really slow that [process] down, but you can certainly speed it up. And one way to speed it up is to inject joints [with corticosteroids] in close proximity to high-speed works.

And so, what we've done in California–and what HISA needs to do–is impress upon the trainers that they need to discontinue this attitude of injecting to run or to work and look at corticosteroids as something that they use as a medical treatment combined with rest and other rehabilitative procedures.

Long-term, intra-articular corticosteroids should be eliminated completely from racing.

Santa Anita | Benoit

TDN: What argument does HISA give in pushing back against adopting California's stricter rules?

GF: You have to realize that much of the rest of the country had [weaker] rules [than California]. And so they say, 'we're getting so much pushback from the rest of the country that we can't do it.'

But what we've argued is to let California have its stricter rules and use us as a model. Then, at some point in time, you can go back to the rest of the country and say, 'well, California's had this rule in place and look what it's done. It's been beneficial. Why don't we adopt it nationwide?'

California is the point of the spear in terms of dealing with the public and the liability of horse racing. I think they should use us as a sort of leader in animal welfare and jockey welfare.

TDN: Do you think HISA's approach on this issue runs counter to their stated mandate of animal welfare and safety?

GF: Correct. What it takes is somebody with enough backbone to stand up to the pushback.

I mean, we got pushback in California, too. But we did what we thought was right and it's proven to be beneficial. Now, the horsemen look at us and say, 'well, we didn't like it in the beginning, but we realize it was worth the sacrifice.'

TDN: Are you worried California, after a sharp downward trend in equine fatalities in recent years, might now see an uptick in fatalities and injuries as a result?

GF: Absolutely. That's what our worry is.

TDN: Wow. Because of this, has the CHRB thought about the possibility of California opting out of HISA–at least until these fixes have been secured?

GF: No, we wouldn't do that. We're supportive of HISA overall. We think the concept of a standard rule nationwide is beneficial to the industry overall. These are growing pains. I think we're better off to work within [HISA]. Us pulling out is just not an option.

The post Greg Ferraro Q&A, Part II: HISA Rollout “Inconsistent and Uneven” appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

CHRB Reports Safety Measures Continue To Protect Horses

California horse racing again experienced a significant decline in the number of horses that died from injuries suffered during racing and training at the state's facilities during the 2022-23 fiscal year that ended June 30, the California Horse Racing Board (CHRB) said in a press release on Saturday.

A total of 26 died last year as a result of musculoskeletal injuries that occurred while racing or training, compared with 39 the previous year. For context, approximately 30,000 race starts and far in excess of 100,000 workouts occur each year from 8,000 to 10,000 horses at CHRB regulated facilities.

“That's still too many fatalities, but it shows that all of the new regulations, policies and procedures that that we've introduced in cooperation with the industry have had a significant effect,” said CHRB Chairman Greg Ferraro. “Our efforts are focused primarily on preventable injuries, and that's what the numbers reflect. I don't know of any racing jurisdiction in the country that even comes close to matching this effort or result.”

In the interest of full transparency, the CHRB also tracks fatalities caused by any non-exercise-related catastrophic injury. The most common cause of death in this other group is gastro-intestinal diseases, such as colic, colitis, and enteritis, followed by respiratory disease. Unfortunately, the number of “other” deaths increased last year, and those 43 deaths, coupled with the 26 due to musculoskeletal injuries, brought the total to 69, or three more than the 66 from the previous year.

“I've considered several times the idea of not counting other deaths, the type that occur among horse populations anywhere in the world, including the popular riding stables and in the wild, but I've always decided that full transparency is the best way to go,” said CHRB Executive Director Scott Chaney.

Those 43 other deaths occurred despite care and treatment by on-site veterinarians and specialized equipment located in stable areas.

“Six of those horses were transported to the veterinary hospital at the University of California, Davis, as well as other local referral hospitals, where experts did their best to save them,” said Dr. Jeff Blea, the CHRB equine medical director. “Illnesses such as severe colic, advanced neurologic cases, and obscure medical conditions, sometimes just are not treatable, as animal and horse owners throughout the world know from personal experience.”

For further context, equine fatalities at CHRB-regulated facilities have declined by 54 percent since 2019, including the “other” category.

 

The post CHRB Reports Safety Measures Continue To Protect Horses appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Sudden Equine Deaths: “This is so frustrating for us”

News out of Churchill Downs last week that two of trainer Saffie Joseph Jr's horses had collapsed and died within days of each other has reignited talk around one of the most confounding–and by extension, frustrating–issues in racing: sudden equine death.

More than four years ago in response to the death of GI-placed Bobby Abu Dhabi (Macho Uno)–what was initially suspected a sudden cardiac-related event–the TDN took a lengthy dive into the issue.

In a nutshell, sudden cardiac deaths oftentimes leave no discernable physical sign for pathologists to piece together a clear diagnostic picture–no major lesions, faulty valves, ruptured arteries or damaged heart tissue for them to point to with authority and say this or that caused the heart to stop.

In a well-considered study published in 2011 looking at post-mortem findings from 268 Thoroughbred racehorses that suffered exercise-related sudden deaths, pathologists made a definite diagnosis in only 53% of cases, a presumptive diagnosis in 25% cases, while 22% of cases were left unexplained. In humans, coincidentally, about one-third of sudden deaths are presumed to be cardiovascular-related but don't actually have any concrete diagnosis.

Veterinary experts remain after all these years largely circumspect when pressed as to exactly what causes these events in racehorses, with fingers pointed towards electrical abnormalities like arrhythmias, genetic predispositions, drug use and faulty valves of the heart.

“We're asking better questions and we're asking more questions,” said Dionne Benson, chief veterinary officer for 1/ST Racing, when asked why progress has been slow in better understanding sudden death cases in racehorses. “But we've just started to ask those questions the last few years.”

Causes
Part of the reason is the infrequency with which these events occur. This paper pinned the number at roughly one sudden death per 10,000 individual starts.

Last Friday, the TDN asked the Horseracing Integrity and Safety Act (HISA)–mandated to record and report all equine fatalities at participating jurisdictions–how many sudden deaths have occurred since the law went into effect on July 1 last year. HISA did not provide an answer.

This study from last year found that sudden equine deaths were more likely during training than during racing, and horses with fewer lifetime starts were at higher risk.

“Exercise intensity appears not to be critically important in precipitating sudden cardiac death in horses,” the researchers summarized, before adding that typically, “sudden cardiac death occurred early in the careers of affected horses.”

A pivotal area of research surrounds so-called “electrical irregularities,” like arrhythmias (an irregular heartbeat), and heart murmurs (the presence of irregular heartbeat sounds).

Indeed, some 50% of racehorses experience cardiac arrhythmias when put under some kind of physical duress. That is one main reasons researchers out of the University of Minnesota are in the middle of a study of some 1,200 Thoroughbreds and Standardbreds with normal heart function at rest, but who develop arrhythmia during exercise.

“It's really hard to know for sure because when a horse dies, the electrical conductivity of the heart stops,” said Molly McCue, a professor and the associate dean for research at the University of Minnesota College of Veterinary Medicine, explaining why there still remains no concrete scientific proof that electrical irregularities cause sudden cardiac death, even though most experts agree that these issues are key to getting to the root of the problem.

In this regard, many veterinary experts bemoan the fact that in this scientific arena, horse racing is in some regards the medieval cousin of human athletics, which has already been closely monitoring and studying the heart's electrical capabilities for many decades, meaning so much of the dynamic possibility of a racehorse's heart remains shrouded in mystery.

Back in early 2015, in a study encompassing 30 racehorses in California, none of the horses suffered arrhythmias, but the authors noted a post-exercise increase in what is called valvular regurgitation, which is when heart valves don't close properly, allowing blood to flow backwards in the heart.

About 20% of healthy Thoroughbreds have some degree of valvular regurgitation when examined–but again, any clinical significance is currently unknown.

Despite the vast body of cardiac research in human athletes, the National Institutes of Health has its eye on the Grayson-Jockey Club funded arrhythmia study “as an interesting model for what happens in young human athletes,” McCue said, with the occurrence of sudden death in horses far higher than in humans.

“The frequency in horses, it's about 10 times more common than it is in people,” McCue said.

Another fast-evolving area of interest concerns genetics. Human science has found a genetic connection to a higher risk of heart disease. In racehorses, any potential genetic correlation with a higher likelihood of sudden death is still largely at lift-off.

McCue and her fellow researchers are taking DNA samples from the same 1200 horses in the arrhythmia study to see if any genetic pattern emerges. McCue calls these two studies “a two-pronged effort” to identify early horses at higher risk of experiencing sudden death.

“One is the genetics, figuring out who is high-risk and who we need to screen and look at really critically. And then two, developing tools that can identify the horses this is most likely to happen in,” said McCue.

“Our hope is that if we can develop computer models that can predict if a horse is more likely to experience severe arrhythmias today, we can then pull that horse from racing,” McCue added.

Some heart problems among horses that suffer sudden death are much easier to diagnose–but structural abnormalities are rare. A 2011 paper found that about 1% of horses who die suddenly suffer a ruptured aorta, which is the largest artery in the body.

Which brings the story around to the presumed connection between drugs and sudden cardiac death–the touchpaper of any high-profile sudden death in racing.

Drugs
“Here's the problem,” said Rick Arthur, former CHRB equine medical director. “People watch CSI and they see them taking a fingernail clipping and they can tell you what you had for lunch three days ago. Life doesn't work that way.”

In other words: Unlike an episode of CSI: NY, which typically wraps with a neat conviction, investigations into sudden racehorse death rarely conclude as tidily, even when a link emerges with a suspected substance.

Just take the case of a Standardbred that died suddenly at Cal Expo in early 2014. The horse, Arthur said, was subsequently found to have abnormally high levels of cobalt (a naturally occurring element) in its system.

The trainer faced no punitive actions because the death occurred before the CHRB passed rules instituting cobalt thresholds in test samples, said Arthur, who equivocated on whether the horse's death could have been definitively linked to an administration of cobalt.

“The cobalt was so high that it could have been associated with it,” Arthur said. “But again, that's when we were suspicious of cobalt–we might have over-interpreted it. But it certainly was very high.”

A recent limited study on six Standardbreds found a possible connection between cardiac arrhythmias (including atrial fibrillation) and levothyroxine–a thyroid supplement linked to the sudden deaths of seven Bob Baffert trained horses between 2011 and 2013.

A subsequent CHRB report noted that the horses had been administered thyroxine, and that use of thyroxine is “concerning in horses with suspected cardiac failure.” However, the report also noted that, because the drug had been administered to all horses in Baffert's care, the use of thyroxine “does not explain why all the fatalities occurred.”

Arthur co-authored a paper finding a “very strong” connection between anticoagulant rodenticide exposure and an increased risk of sudden death during exercise from unusual hemorrhaging. Strong suspicions surround the bronchodilator clenbuterol, which has been proven to increase heart muscle. Iodine–commonly found in seaweed-based supplements—has also been linked to arrhythmia.

“Certainly there are other things. Horses can build up levels of selenium [a naturally occurring mineral] which can cause sudden death,” Benson said. “You can also have things in the feed like monensin [a polyether antibiotic toxic to horses].”

In human sports the rise of erythropoietin [EPO]–a synthetic form of a natural metabolic product that thickens the blood–was linked to the deaths of multiple young professional cyclists and other athletes. Has illicit EPO use in horseracing ever been linked to any sudden equine deaths?

“No–at least not in California,” said Arthur, who said that EPO would have the same effect in horses' blood by thickening it though increased blood cell count, a process called polycythemia.

But a diagnostic complication in this issue, Arthur added, is how horses are “natural blood-dopers because of their huge spleens.”

Virus
 Springtime, of course, is equine virus hunting season. And viral infections are known to cause myocarditis, inflammation of the heart muscle.

“It's always a possibility,” said Francisco Uzal, coordinator of the California Animal Health and Food Safety Laboratory post-mortem program for the CHRB, when asked if a viral infection could explain the two recent Joseph-trained sudden deaths.

Uzal added, however, that while he has never seen during any sudden death necropsy instances of severe myocarditis–which would show up under the under the microscope as large lesions–“we've found in a number of sudden-death horses really, really mild and minor myocarditis.”

More tellingly, said Uzal, is how the same minor heart lesions appeared in horses that didn't suffer sudden death events. “You see it in normal horses, too. So, what does it mean? Probably nothing,” he said.

“This is so frustrating for us,” Uzal added. “We go home empty-handed most of the time.”

Which leads to the finer points of the actual necropsy process. Even if a substance suspected of increasing the likelihood of sudden equine death shows up at what are presumed elevated levels during the necropsy process, it doesn't necessarily indicate a smoking gun.

Take thyroxine, an endogenous substance, meaning it's produced naturally inside the body and therefore harder to evaluate than a medication with its own specific pharmacological signature.

“When you do a test, you compare what you find with the normal values in a normal animal in a living horse. There are no normal values for dead horses,” said Uzal, highlighting how difficult it is to determine baseline levels for endogenous substances like thyroxine.

“But having said that, we have compared the thyroxine found in postmortem blood in sudden death horses with the same in normal horses, and we found no difference,” he said.

Helpful to better understanding the underlying causes of sudden cardiac death in racehorses would be if all necropsies were made equal.

Uzal co-authored a 2017 paper highlighting how “autopsy technique” varies depending on personnel and “institutional preferences.”

As Uzal puts it, “pathology is a science as well as an art. You talk to 10 different pathologists, you hear 10 different stories. We have tried very hard to standardize, and we are still fighting for it.” In this regard, could federal intervention be on its way?

HISA's racetrack safety rules require all horses that die or are euthanized on licensed grounds at all participating jurisdictions undergo a necropsy. But the rules appear broad and fail to mandate more specific uniform rules on necropsy protocols.

HISA did not respond to a series of questions on the issue of necropsies. This includes whether every horse that has died during racing and training at jurisdictions under HISA's oversight have undergone necropsy examinations, and whether HISA has indeed instituted uniform protocols or guidelines for the actual necropsy process.

Future
In a bid to fill in some of the glaring blanks surrounding sudden death, UC Davis has begun storing necropsy samples taken from sudden death horses in a large freezer to be retrieved and re-tested in the advent of more sophisticated analytical technologies.

“The other thing we do from each horse, we have multiple different containers. So, the idea is we can provide it to different people,” said Uzal.

More contemporaneously, Uzal and his team are poised to begin studying the training records of horses that suffer sudden cardiac deaths for any possible explanatory patterns.

“We want to see if there's something in the training that could give us a clue of what's happening,” said Uzal. “We want to see if it's possible–and I don't know if that's the right expression–but see if it's possible that some horses are trained to the point of exhaustion.

“I don't know the answer–it's pure speculation,” Uzal added. “It could be nothing, or it could be something.”

The post Sudden Equine Deaths: “This is so frustrating for us” appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights